Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Melodiol Global Health (AU:ME1)
ASX:ME1
Melodiol Global Health (ME1) Share Price & Analysis
12 Followers
ME1 Stock Chart & Stats
Day’s Range<AU$0.01 - <AU$0.01
52-Week Range― - ―
Previous CloseAU$0.0025
Volume2.92M
Average Volume (3M)N/A
Market Cap
$2.14M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Melodiol Global Health News
PremiumCompany Announcements
Melodiol’s Subsidiary Mernova Expands with Strong Sales
PremiumCompany Announcements
Melodiol Issues New Shares, Ensures CompliancePremiumCompany Announcements
Melodiol Global Issues Shares to Creditor
PremiumCompany Announcements
Melodiol Plans Massive New Securities Issue
PremiumCompany Announcements
Melodiol Global Health Plans Major Securities Issuance
PremiumCompany Announcements
Melodiol Global Health’s Virtual Shareholder Meeting
PremiumCompany Announcements
Melodiol Announces New Group CFO AppointmentPremiumCompany Announcements
Melodiol Global Health’s Revenue Soars in Q1 FY24Options Prices
Currently, No data available
---
Ownership Overview
65.26% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
34.74% Public Companies and
Individual Investors
ME1 FAQ
What was Melodiol Global Health’s price range in the past 12 months?
Currently, no data Available
What is Melodiol Global Health’s market cap?
Currently, no data Available
When is Melodiol Global Health’s upcoming earnings report date?
Melodiol Global Health’s upcoming earnings report date is Aug 28, 2024 which is in 110 days.
How were Melodiol Global Health’s earnings last quarter?
Melodiol Global Health released its earnings results on Feb 29, 2024. The company reported -AU$0.117 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.117.
Is Melodiol Global Health overvalued?
According to Wall Street analysts Melodiol Global Health’s price is currently Overvalued.
Does Melodiol Global Health pay dividends?
Melodiol Global Health does not currently pay dividends.
What is Melodiol Global Health’s EPS estimate?
Melodiol Global Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Melodiol Global Health have?
Currently, no data Available
What happened to Melodiol Global Health’s price movement after its last earnings report?
Melodiol Global Health reported an EPS of -AU$0.117 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Melodiol Global Health?
Currently, no hedge funds are holding shares in AU:ME1
---
Melodiol Global Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
AU:ME1 Sentiment 50%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
―
20 days / 200 days
Momentum
124.48%
12-Months-Change
Fundamentals
Return on Equity
-385.89%
Trailing 12-Months
Asset Growth
-49.55%
Trailing 12-Months
Company Description
Melodiol Global Health
Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel and Australia. The company derives prime revenue from the Europe and Middle East regions.
---
---